Skip to search formSkip to main contentSkip to account menu

GRL 06579A

Known as: GRL-06579A, GRL06579A 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Bridged Bicyclo Compounds, HeterocyclicSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Importance of polar solvation and configurational entropy for design of antiretroviral drugs targeting HIV-1 protease.
Both KNI-10033 and KNI-10075 are high affinity preclinical HIV-1 protease (PR) inhibitors with affinities in the picomolar range… 
Highly Cited
2012
Highly Cited
2012
Origin of decrease in potency of darunavir and two related antiviral inhibitors against HIV-2 compared to HIV-1 protease.
Acquired immune deficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV) type 1 and 2 (HIV-1 and HIV-2… 
2008
2008
Chiral-catalyst-based convergent synthesis of HIV protease inhibitor GRL-06579A.
Catalytic asymmetric synthesis of GRL-06579A (1), an HIV-1 protease inhibitor effective against multi-protease-inhibitor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)